Pharmacopoeia Of The People 39-s Republic Of China Pdf

Pharmacopoeia of the People's Republic of China (ChP) is the official, statutory compendium of drug standards for both Traditional Chinese Medicine (TCM) and Western medicines. It is compiled by the Chinese Pharmacopoeia Commission

• Volume I: Contains standards for Traditional Chinese Medicines, processed slices, oils, fats, and single ingredients derived from TCM.
• Volume II: Contains standards for chemical drugs, antibiotics, biochemical drugs, and radiopharmaceuticals.
• Volume III: Contains standards for biological products (vaccines, blood products, recombinant biologics).
• Volume IV: Contains the General Notices and General Requirements (analytical methods, reagents, apparatus). It also includes the "General Guidelines for the Quality of Excipients."

• Pharmacopoeias are updated by supplements or new editions. Confirm you reference the edition date and check for post-publication amendments, notices, or commission circulars affecting monographs.

ChP 2020 (Current in Force):

This edition became effective on December 30, 2020. It contains 5,911 monographs across four volumes. An official English translation has been available since March 2023. Volume Structure (2020 Edition) The pharmacopoeia is organized into four distinct volumes: Volume I: Traditional Chinese Medicine (TCM) monographs. pharmacopoeia of the people 39-s republic of china pdf

• Official Purchase: Available through the China Pharmaceutical Science and Technology Press or authorized distributors (often as a multi-volume set, with price ~¥300–500+).
• Institutional Access: Universities, regulatory bodies, and pharmaceutical companies may subscribe via platforms like CNKI or other Chinese scientific databases.
• Beware of Unofficial Copies: Free PDFs circulating online may be outdated, incomplete, or violate copyright. Always verify against the official edition for regulatory use.

1. Standardization of Medicinal Products: It provides standardized specifications for the quality of drugs to ensure their safety, efficacy, and consistency.
2. Regulatory Compliance: It serves as a reference for regulatory agencies to evaluate and approve drugs for use in China.
3. Pharmaceutical Industry: Manufacturers use it to ensure their products meet the required standards.
4. Healthcare Professionals: It offers a reference for healthcare professionals on the drugs they prescribe, including dosing and potential interactions.

International Harmonization

: Further aligns Chinese drug standards with international norms by incorporating ICH Q4B guidance principles and other international technical requirements. Pharmacopoeia of the People's Republic of China (ChP)